…
Cancer Type: Liver
ESMO Asia 2023 Symposium – HCC illuminated: Exploring future frontiers with systemic immunotherapies
![ESMO Asia 2023 Symposium - HCC illuminated: Exploring future frontiers with systemic immunotherapies ESMO Asia 2023 presentation slide chong toh HCC illuminated 1 ESMO Asia 2023 presentation slide chong toh HCC illuminated 1](https://clinicalvalue.com/wp-content/uploads/2024/03/ESMO-Asia-2023-presentation-slide-chong-toh-HCC-illuminated_1-1280x720.png)
Missed the satellite symposium session from ESMO Asia 2023? Access the webcast recording here….
Development and Clinical Validation of a Novel Algorithmic Score (GAAD) for the Detection of Early-stage Hepatocellular Carcinoma
![Development and Clinical Validation of a Novel Algorithmic Score (GAAD) for the Detection of Early-stage Hepatocellular Carcinoma EASL ILC 2023 poster piratvisuth development clinical validation and implementation of a novel page 0001 EASL ILC 2023 poster piratvisuth development clinical validation and implementation of a novel page 0001](https://clinicalvalue.com/wp-content/uploads/2024/03/EASL-ILC-2023-poster-piratvisuth-development-clinical-validation-and-implementation-of-a-novel_page-0001-1280x714.jpg)
This study aims to establish and train the algorithm coefficients, and clinically validate the performance of the GAAD algorithm in differentiating HCC and benign chronic liver disease (CLD), across different regions and aetiologies….